HomeNTLX • CVE
add
Neurothera Labs Inc
Previous close
$0.17
Year range
$0.16 - $0.26
Market cap
14.43M CAD
Avg Volume
3.07K
P/E ratio
-
Dividend yield
-
Primary exchange
CVE
Market news
MarketWatch
6 hours ago
S&P 500 hits record high on Christmas Eve for first time in more than a decade
0.32%
0.60%
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | 236.00K | -9.23% |
Operating expense | 260.00K | -23.08% |
Net income | -94.00K | 44.38% |
Net profit margin | -39.83 | 38.72% |
Earnings per share | — | — |
EBITDA | -46.00K | 40.52% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 71.00K | — |
Total assets | 1.59M | — |
Total liabilities | 320.00K | — |
Total equity | 1.27M | — |
Shares outstanding | — | — |
Price to book | — | — |
Return on assets | — | — |
Return on capital | — | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -94.00K | 44.38% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
Founded
2021
Headquarters
